Acorda Therapeutics, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Acorda Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q1 2024.
  • Acorda Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $114K.
  • Acorda Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was -$41M, a 245% decline year-over-year.
  • Acorda Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was -$43.2M, a 241% decline from 2022.
  • Acorda Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $30.7M.
  • Acorda Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was -$5.12M, a 36.6% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$41M $114K +$2.15M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$43.2M -$38.1M -$40.5M -1667% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$2.63M -$1.06M -$2.47M -175% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$155K -$1.97M -$28.5M -107% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $28.4M -$2.04M -$2.3M -890% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $30.7M $2.43M +$764K +45.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $29.9M $1.42M +$4.52M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $25.4M $26.6M +$27.1M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$1.71M $258K +$3.41M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$5.12M $1.67M +$4.78M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 -$9.9M -$3.11M -$4.57M -312% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$5.33M -$531K -$1.1M -193% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$4.23M -$3.15M +$3.85M +55% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$8.07M -$3.11M -$2.31M -290% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-18
Q3 2020 -$5.76M $1.47M +$1.45M +8518% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$7.21M $571K +$357K +167% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$7.57M -$7M -$6.28M -879% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$1.28M -$798K +$62.3M +98.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$63.5M $17K -$38M -100% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$25.6M $214K -$8.14M -97.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$17.5M -$715K -$4.19M -121% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$13.3M -$63.1M -$11.1M -21.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 -$2.15M $38M +$19.1M +101% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$21.2M $8.36M +$2.89M +52.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$24.1M $3.48M +$4.4M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$28.5M -$51.9M -$53M -5188% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 $24.4M $18.9M +$15.8M +524% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $8.6M $5.47M +$6.44M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $2.15M -$918K +$8.82M +90.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$6.67M $1.02M +$9.57M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 -$16.2M $3.02M -$14.7M -83% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$1.49M -$972K -$2.1M -186% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $612K -$9.74M -$7.7M -378% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $8.31M -$8.55M -$5.53M -183% Oct 1, 2015 Dec 31, 2015 10-K/A 2018-03-09
Q3 2015 $13.8M $17.8M +$13.2M +292% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $603K $1.13M -$4.9M -81.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $5.51M -$2.04M -$4.83M -173% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $10.3M -$3.03M -$9.46M -147% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $19.8M $4.54M +$1.02M +29.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $18.8M $6.03M +$1.79M +42.1% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $17M $2.79M +$4.57M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $12.4M $6.44M +$138M Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 -$126M $3.51M +$2.98M +559% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 -$129M $4.25M +$3.97M +1417% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$133M -$1.78M -$2.15M -577% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 -$131M -$132M -$132M -53275% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 $1.43M $533K -$453K -45.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $1.89M $280K +$218K +352% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $1.67M $372K +$255K +218% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $1.41M $248K +$248K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-03
Q3 2011 $1.17M $986K +$986K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $179K $62K +$62K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 $117K $117K +$117K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q4 2010 $0 $0 Oct 1, 2010 Dec 31, 2010 10-K 2012-02-28
Q3 2010 $0 Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 $0 Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
Q1 2010 $0 Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.